Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Barrett Esophagus 4 Breast Neoplasms 3 Pancreatic Neoplasms 2 Lymphoma, B-Cell, Marginal Zone 2 Inflammation 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Obesity 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colorectal Neoplasia 1 Chemotherapy Effect 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 165 fludarabine phosphate 110 Peripheral Blood Stem Cell Transplantation 94 Mycophenolic Acid 88 Whole-Body Irradiation 81 Etoposide 81 Tacrolimus 73 Busulfan 68 Melphalan 67 Filgrastim 66 fludarabine 62 Radiotherapy 56 Doxorubicin 54 Cyclosporine 54 Rituximab 50 Brentuximab Vedotin 48 Antilymphocyte Serum 47 Granulocyte Colony-Stimulating Factor 42 Vinblastine 41 Methotrexate 38 Dacarbazine 37 Cytarabine 35 Gemcitabine 34 Nivolumab 30 Bleomycin 29 Carmustine 28 Vincristine 25 Prednisone 25 Sirolimus 24 Bendamustine Hydrochloride 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hodgkin Disease × Omeprazole × Clear all

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡